- Consumer Products
- Latest 53.21
- Currency US$
- Change -0.05
- Percent Change -0.094 %
- Volume 3,597,287
- Wed Oct 22, 2014 04:02 PM EDT NYSE data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jul 31||$1.22||Oct 30||$1.21|
12 months ended Oct 23, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.